bitifrin 0.3 mg/ml + 5 mg/ml eye drops, solution
farmaprojects s.a. - bimatoprost; timolol maleate - eye drops, solution - timolol, combinations
sturiban eye drops solution 0.1mg/ml
actavis group ptc ehf - bimatoprost - eye drops, solution - bimatoprost 0.1 mg/ml - ophthalmologicals
sturiban eye drops solution 0.3mg/ml
actavis group ptc ehf - bimatoprost - eye drops, solution - bimatoprost 0.3 mg/ml - ophthalmologicals
bimatoprost actavis
teva pharma (new zealand) limited - bimatoprost 0.1 mg/ml; - eye drops, solution - 0.1 mg/ml - active: bimatoprost 0.1 mg/ml excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - bimatoprost actavis is indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.
bimatoprost actavis
teva pharma (new zealand) limited - bimatoprost 0.3 mg/ml; - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - bimatoprost actavis is indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.
ganfort pf 0.3/5 bimatoprost 0.3 mg/ml and timolol (as maleate) 5.0 mg/ml eye drops
abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
ganfort 0.3/5 bimatoprost 0.3 mg/ml & timolol (as maleate) 5.0 mg/ml eye drops bottle
abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; hydrochloric acid; sodium chloride - ganfort eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
bimatoprost 300micrograms/ml eye drops
aspire pharma ltd - bimatoprost - eye drops - 300microgram/1ml
iricryn 0.3 mg/ml eye drops, solution
farmaprojects s.a. - bimatoprost - eye drops, solution - bimatoprost
lumigan bimatoprost 300 micrograms/ml eye drops bottle
abbvie pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; dibasic sodium phosphate heptahydrate; sodium chloride - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.